Onconetix, Inc. Fair Value Adjustment of Warrants
Onconetix, Inc. (ONCO) had Fair Value Adjustment of Warrants of $14.90 million as of 2025-12-23, per its 10-K filed 2026-03-13.
Financial Statements › Cash Flow › Other Cash Flow Items
us-gaap:FairValueAdjustmentOfWarrants · last filed 2026-03-13
- Onconetix, Inc. fair value adjustment of warrants for the quarter ending 2025-09-30 was -$1.93M.
- Onconetix, Inc. fair value adjustment of warrants for the quarter ending 2025-06-30 was $229.00.
- Onconetix, Inc. fair value adjustment of warrants for the quarter ending 2025-03-31 was $9.79K.
- Onconetix, Inc. fair value adjustment of warrants for the quarter ending 2024-12-31 was -$1.22M.
- Onconetix, Inc. fair value adjustment of warrants for fiscal 2024 was -$1.25M, a 1459.69% decline from fiscal 2023.
- Onconetix, Inc. fair value adjustment of warrants for fiscal 2023 was $91.97K.
- Onconetix, Inc. fair value adjustment of warrants for fiscal 2022 was -$61.41K.
| Period end | Fair Value Adjustment of Warrants | Fair Value Adjustment of Warrants 1 month | Fair Value Adjustment of Warrants 3 month | Fair Value Adjustment of Warrants 6 month | Fair Value Adjustment of Warrants 9 month | Fair Value Adjustment of Warrants 12 month | Fair Value Adjustment of Warrants 12 month as first filed |
|---|---|---|---|---|---|---|---|
| 2025-12-23 | $14.90M 10-K · filed 2026-03-13 | ||||||
| 2025-09-30 | -$1.93M 10-Q · filed 2025-11-13 | -$1.93M derived: sum of 2 quarters · filed 2025-11-13 | -$1.93M 10-Q · filed 2025-11-13 | -$3.14M derived: sum of 4 quarters · filed 2025-11-13 | |||
| 2025-06-30 | $229.00 10-Q · filed 2025-08-14 | $10.02K 10-Q · filed 2025-08-14 | -$1.21M derived: sum of 3 quarters · filed 2025-08-14 | -$1.24M derived: sum of 4 quarters · filed 2025-08-14 | |||
| 2025-03-31 | $9.79K 10-Q · filed 2025-06-12 | -$1.21M derived: sum of 2 quarters · filed 2025-06-12 | -$1.24M derived: sum of 3 quarters · filed 2025-06-12 | ||||
| 2024-12-31 | -$1.22M derived: 10-K 12 month − 10-Q 9 month · filed 2025-06-02 | -$1.25M derived: sum of 2 quarters · filed 2025-06-02 | -$1.25M 10-K · filed 2025-06-02 | ||||
| 2024-09-30 | -$30.45K 10-Q · filed 2024-12-10 | -$30.45K 10-Q · filed 2024-12-10 | |||||
| 2023-12-31 | -$7.82K derived: 10-K 12 month − 10-Q 9 month · filed 2025-06-02 | $91.91K derived: sum of 2 quarters · filed 2025-06-02 | $93.58K derived: sum of 3 quarters · filed 2025-06-02 | $91.97K 10-K · filed 2025-06-02 | $729.90K 10-K · filed 2024-04-11 | ||
| 2023-09-30 | $99.73K 10-Q · filed 2024-12-10 | $101.40K derived: sum of 2 quarters · filed 2024-12-10 | $99.79K 10-Q · filed 2024-12-10 | $71.75K derived: sum of 4 quarters · filed 2024-12-10 | |||
| 2023-06-30 | $1.67K 10-Q · filed 2024-08-29 | $59.00 10-Q · filed 2024-08-29 | -$27.98K derived: sum of 3 quarters · filed 2024-08-29 | -$31.05K derived: sum of 4 quarters · filed 2024-08-29 | |||
| 2023-03-31 | -$1.61K 10-Q · filed 2023-05-12 | -$29.65K derived: sum of 2 quarters · filed 2023-05-12 | -$32.72K derived: sum of 3 quarters · filed 2023-11-17 | -$63.02K derived: sum of 4 quarters · filed 2023-11-17 | |||
| 2022-12-31 | -$28.04K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-09 | -$31.11K derived: sum of 2 quarters · filed 2023-11-17 | -$61.41K derived: sum of 3 quarters · filed 2023-11-17 | -$61.41K 10-K · filed 2023-03-09 | |||
| 2022-10-31 | $10.00K 10-K · filed 2024-04-11 | ||||||
| 2022-09-30 | -$3.07K 10-Q · filed 2023-11-17 | -$33.38K derived: sum of 2 quarters · filed 2023-11-17 | -$33.38K 10-Q · filed 2023-11-17 | ||||
| 2022-06-30 | -$30.30K 10-Q · filed 2023-10-20 | -$30.30K 10-Q · filed 2023-10-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| HCW Biologics Inc. (HCWB) | United States | $0.004B | -6.15 |
| REVELATION BIOSCIENCES, INC. (REVB) | United States | $0.004B | |
| Aptevo Therapeutics Inc. (APVO) | United States | $0.003B | |
| Sunshine Biopharma Inc. (SBFM) | $0.003B | ||
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | United States | $0.004B | -0.59 |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Lakewood-Amedex Biotherapeutics Inc. (LABT) | United States | $0.004B | |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |